Evidence map›Paper›PMID 17563383›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2007

Real-time analysis of uptake and bioactivatable cleavage of luciferin-transporter conjugates in transgenic reporter mice.

Paul A Wender, Elena A Goun, Lisa R Jones, Thomas H Pillow, Jonathan B Rothbard, Rajesh Shinde, Christopher H Contag

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 82 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Caged luciferins for bioluminescent activity-based sensing.Current opinion in biotechnology · 2019
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Paul A WenderDepartment of Chemistry, Stanford University, Stanford, CA 94305-5080, USA. wenderp@stanford.edu
Elena A Goun
Lisa R Jones
Thomas H Pillow
Jonathan B Rothbard
Rajesh Shinde
Christopher H Contag
Division of Chemistry · USStanford University · US

Funding

SYNTHETIC STUDIES RELATED TO CANCER RESEARCH/TREATMENTR01CA031845 · NCI · STANFORD UNIVERSITY · PI PAUL Anthony WENDER · 1985 to 2026
$6.9M
SYNTHETIC STUDIES ON TUMOR PROMOTERS AND INHIBITORSR01CA031841 · NCI · STANFORD UNIVERSITY · PI WENDER, PAUL ANTHONY · 1985 to 2014
$4.8M
Synthetic Studies Related to Cancer Research/TreatmentR37CA031845 · NCI · STANFORD UNIVERSITY · PI WENDER, PAUL ANTHONY · 2006 to 2015
$4.5M
SYNTHETIC STUDIES ON TUMOR PROMOTERS AND INHIBITORSR37CA031841 · NCI · STANFORD UNIVERSITY · PI WENDER, PAUL · 1993 to 1999
–
NCI NIH HHS CA31841NCI NIH HHS CA31845NCI NIH HHS R01 CA031841NCI NIH HHS R01 CA031845NCI NIH HHS R37 CA031841NCI NIH HHS R37 CA031845
6 · The paper itself

Abstract

Many therapeutic leads fail to advance clinically because of bioavailability, selectivity, and formulation problems. Molecular transporters can be used to address these problems. Molecular transporter conjugates of otherwise poorly soluble or poorly bioavailable drugs or probes exhibit excellent solubility in water and biological fluids and at the same time an enhanced ability to enter tissues and cells and with modification to do so selectively. For many conjugates, however, it is necessary to release the drug/probe cargo from the transporter after uptake to achieve activity. Here, we describe an imaging method that provides quantification of transporter conjugate uptake and cargo release in real-time in animal models. This method uses transgenic (luciferase) reporter mice and whole-body imaging, allowing noninvasive quantification of transporter conjugate uptake and probe (luciferin) release in real time. This process effectively emulates drug-conjugate delivery, drug release, and drug turnover by an intracellular target, providing a facile method to evaluate comparative uptake of new transporters and efficacy and selectivity of linker release as required for fundamental studies and therapeutic applications.

Indexed as

Genes, ReporterAnimalsBiological Transport, ActiveDisulfidesDose-Response Relationship, DrugFirefly LuciferinInjections, IntradermalLuminescenceLuminescent MeasurementsMembrane Transport ProteinsMiceMice, TransgenicMolecular StructureWhole Body ImagingDisulfidesFirefly LuciferinMembrane Transport Proteins

Identifiers

PMID17563383
PMCPMC1965515
OpenAlexW1968248620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.